Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Hyaluronic Acid vs Dextrose Prolotherapy for TMJ Internal Derangement
NCT07911358Not yet recruiting
- Sponsor
- Allama Iqbal Medical College
- Start
- Jan 2027
- Primary completion
- Jan 2028
- Countries
- 1
01
Overview
Randomised trial in temporomandibular joint internal derangement (TMJID) comparing Group A: Dextrose Prolotherapy with Group B: Sodium Hyaluronic Acid (2 arms). Primary endpoints: Mean Change in Pain Scores at 3 months and Maximum Inter-Incisal Opening at 3 months. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
dextrosesodium hyaluronate
03
Conditions
temporomandibular joint internal derangement (TMJID)
Beyond the preview
Go deeper on NCT07911358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07911358.